Lianantonakis E, Kotroutsos E, Zacharakopoulou E
Behav Neuropsychiatry. 1976;8(1-12):36-8.
The purpose of this brief work is to study and make a general survey of the problem of obesity as related in whatever way, to the use of psychotropic drugs. It is a fact learned through clinical experience and knowledge by clinics and researchers working in the field of psychotropic drugs that patients subjected to extended therapy with such drugs show, in a considerable number of cases, an increase in body weight. We consider that this obesity, the pathogenetic cause of which is attributed to the action of psychotropic drugs, constitutes a serious disadvantageous side-effect of those drugs, since a large number of mental patients discontinue their drug therapy for the reasons that it is responsible for the increase in their body weight. It is a known fact discontinuation of the psychotropic drug treatment generally results in a relapse of their mental disorder.
这项简短工作的目的是研究并全面审视肥胖问题,该问题与精神药物的使用存在任何形式的关联。通过临床经验以及精神药物领域的诊所和研究人员的知识可知,接受此类药物长期治疗的患者在相当多的病例中会出现体重增加。我们认为,这种肥胖的致病原因归因于精神药物的作用,它构成了这些药物严重的不良副作用,因为大量精神疾病患者因体重增加而停止药物治疗。众所周知,停止精神药物治疗通常会导致其精神障碍复发。